Ultrasonography has been added to the rheumatologist’s toolbox in recent years as a sensitive imaging modality in assessment of inflammatory arthritis but its relationship with tender or swollen joints is not quite clear. A large study of early, DMARD naive PsA patients shows that swollen joints, but not tender joints are associated with ultrasound power doppler synovitis.
All News
Article
Article
Here are my highlights from day four, Monday, of the ACR 2020 Convergence.
Vaccine Immunogenicity with Tofacitinib
Long-Term Benefits of Ixekizumab in Psoriatic Arthritis
https://t.co/CaGVSvFzVd https://t.co/ktdG5nt96f
PsA Studies: Entheses, Ultrasound, Swollen not Tender Joints: Dr. Antoni Chan ( @synovialjoints) #ACR20
https://t.co/S6Nj9eWnTF https://t.co/qDOT2TwfHl
Watch our video on Psoriatic Disease with Dr. Lianne Gensler #ACR20
https://t.co/77D30OfbOJ https://t.co/vEm5bcNsRb
Have you read this article? Diagnostic Delay in Psoriatic Arthritis: What are the Consequences? by Dr. Olga Petryna ( @DrPetryna ).
https://t.co/En1UdcCuae https://t.co/wcROaTkK0O
#BestACR20Tweets
"RT @KDAO2011 : Meta-analysis of studies - 4104 pregnancies axSpa/PsA: higher risk for: preterm labor, small for gestational age, C-section
No change in miscarriage/stillbirth, gest.diabetes
#ACR20, @rheumnow Abstr#1771
https://t.co/xl1YyRPavX"
Treat to Target for PsA Patients Abstracts: Dr. Rachel Tate ( @uptoTate)
https://t.co/uYBMNiyUqY https://t.co/sUTN187ilp
New podcast out now on our site #ACR20
Mid-Meeting Recap: Psoriatic Arthritis, Gout Patient Outcomes on Low-Dose Steroids, Giant Cell Arteritis Panel Vaccination w/ Shingrix: Does it work for patients on JAKi? Is it safe?
https://t.co/roc1Qjec5R https://t.co/gSkkj2Kl0m
Listen to the Rheum Now podcast on Day 4 of the #ACR20 meeting.
Topics: Belimumab in Lupus Nephritis, Enthesitis in PsA, Equity & Inclusion in Rheumatology Education, Osteoarthritis Studies, Outcomes of COVID in Rheumatic Disease Patients
https://t.co/1PShHqXa0j https://t.co/9ALWsjWqpB
Vaneet K Sandhu, MD
Tweet
Thank you Prof Laure Gossec for discussing recent data in Psoriatic Arthritis #ACR20 #ACRambassador https://t.co/f0o8m5K0d2 https://t.co/Wm0sQDUeY1
Upadacitinib vs. Adalimumab vs. PBO in PsA Phase 3 RCT ⬇️MSK symptoms, PsO, function, pain, fatigue, rads progression in UPA *⃣UPA15 non-inferior to ADA for ACR20, UPA30 superior *⃣Similar VTE in all arms @RheumNow #ACR20 Abs#2026 https://t.co/OHzIjXKqAu
Deucravacitinib TYK2i for PsA
Phase2b 16wk, Double-blind, Placebo, RCT
⬆️ACR20/50/70 response vs. PBO
⬆️HAQ-DI response, enthesitis resolution, MDA vs. PBO
*⃣No serious AE
@RheumNow #ACR20 Abs#L03 #ACRbest https://t.co/9Klu2aeEj2
Deucravacitinib is a novel Tyrosine kinase 2 (TYK2) prev shown efficacy in psoriasis, now effective in PsA. PhII trial of 203 PsA patients showed wk 16 significant improvement in ACR20/50/70, enthesitis, SPARC scores. #ACR20 Abstr#L03 https://t.co/LGokmmlyrc
@rheumnow #acr20 #absL03 RCDB PC ph2 trial TYK2i Deucravacitinib for PsA: ACR 20 at 16wk 6 mg 52.9% & 12 mg 62.7% vs PBO 31.8%. csDMARD & TNFi failure included. no serious infections, herpes zoster, opportunistic infections, or thrombotic events https://t.co/WVm4llPv5i
No need to stop Tofa w/the flu?
👉Posthoc analysis 7964 Tofa pts over 14-15 flu seasons reported similar flu rates compared to ADA, MTX, PCB.
👉Tofa cont. in 70% pts; 28.8% stopped; mean days to resolution similar.
Abstr#L04 #ACR20 @rheumnow #ACRBest
https://t.co/rZXKRVl7uK
sheila
Tweet
#Curcumin for PsA & RA?🤔
Results suggest curcumin's efficacy on pt's perceived symptom alleviation & poss correlation w/ dose and length of tx. @RheumNow #ACR20 abs1230 https://t.co/xUxUEW02ww
Dr. Antoni Chan
Tweet
Lots of interesting studies in Spondyloarthritis including AxSpA and PsA at #ACR20 @RheumNow https://t.co/tIyqyMdmTf
Janet Pope
Tweet
PsA still has ^mortality vs general marched pop’n. Can we do better for our pts? Abstr#1476 @RheumNow @CRASCRRheum #ACR20 https://t.co/aDkTF9dFF0
